Samsung’s new sleep apnea detection feature has been approved by the U.S. Food and Drug Administration (FDA) and will be launched in the United States later this year, the tech company announced on Friday. Samsung received De Novo clearance from the FDA, which also approves medical devices, for its sleep apnea detection feature, a recognition typically granted to new healthcare products. The same feature was previously approved by the Korean Ministry of Food and Drug Safety in October.
According to Samsung’s website, the Health Monitor app available on Galaxy Watch can also detect irregular heart rhythms and monitor blood pressure.
Obstructive sleep apnea, as stated by the National Sleep Foundation, is a medically diagnosable condition in which narrowed or blocked airways disrupt sleep, causing snoring or other health problems. Sleep apnea can result in fatigue, worsen sleep quality, and increase the risk of high blood pressure, heart failure, and even stroke, according to the National Council on Aging, which also reports that it affects over 39 million Americans. Samsung’s sleep apnea detection feature is designed for users over the age of 22 who suspect they may have moderate to severe sleep apnea but have not yet been diagnosed. However, Samsung advises individuals who experience symptoms of sleep apnea to consult a doctor rather than relying solely on the watch’s data.
The new sleep apnea detection feature is expected to become available for Samsung Galaxy smartwatch users in the United States between July and October of this year, as reported by Samsung.
In contrast to its competitor Apple, Samsung does not offer a dedicated sleep apnea detection feature, though the Apple Watch has some sleep tracking capabilities, including respiratory rate tracking. However, Apple states that its respiratory rate tracking is “not intended for medical purposes.”
FAQ Section:
The source of the article is from the blog crasel.tk